Clinicopathologic and molecular characterization of low-grade, early-stage, and HER2-positive invasive breast carcinoma. Hunter N, Han L, Corbin H, Konnick EQ, et al. Am J Clin Pathol 2025;163:854-865.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hunter N, Han L, Corbin H, Konnick EQ, et al. Clinicopathologic and molecular characterization of low-grade, early-stage, and HER2-positive invasive breast carcinoma. Am J Clin Pathol 2025;163:854-865.
PMID: 40043195